|
|
Much research is devoted to uncovering why some people chronically overeat and how medicine might be able to help them. Severe childhood obesity may be caused by partial loss of a growth factor receptor, reports a study in the November issue of Nature Neuroscience.
Stephen O'Rahilly and colleagues, found in a severely obese and mildly retarded child that one of the two copies of the gene for the receptor TrkB was mutated and thereby rendered inactive. TrkB is present on the surface of nerve cells, where it binds the nervous system growth factor BDNF and transmits its signal to the cell interior. The BDNF/TrkB system is well known for its role in supporting the survival of nerve cells, and it was quite a surprise when a few years ago an American group of researchers showed that lack of BDNF or TrkB could cause severe obesity in mice. The current paper's authors now report the first human in whom obesity may be caused by insufficient BDNF/TrkB signaling; their patient does not carry any mutations in other genes linked to obesity. The authors screened another 288 people with severe childhood-onset obesity for defects in the TrkB gene, and found five different mutations in five patients. These results do not yet prove that TrkB mutations are a significant cause of morbid obesity, but they do suggest that TrkB signaling is involved in body weight regulation, and that it could be a target for drug development. Author contact Stephen O'Rahilly (Cambridge Institute for Medical Research and Addenbrooke's Hospital, University of Cambridge, UK) Tel: +44 1223 336 855, E-mail: sorahill@hgmp.mrc.ac.uk Also available online. (C) Nature Neuroscience press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|